EV
-
Aslan Pharmaceuticals selects PharmaNet/i3 as partner for oncology development
Aslan Pharmaceuticals has selected PharmaNet/i3 as a partner supporting the development of their oncology portfolio in Asia.
EV | 02 May 2012
-
Quintiles, Biofund to expand clinical development capabilities in Russia
Russian venture company (RVC), Biofund, and Quintiles announced an agreement to support expansion of clinical development services within the Russian Federation, the world’s ninth most populous country.
EV | 13 April 2012
-
Technology gains renewing interest in needle arrays as drug delivery devices
Evolution in drug delivery device design is changing the way a growing number of therapeutic substances are administered.
EV | 12 April 2012
-
Life Technologies appoints head of global research and development
Life Technologies announced that Alan B Sachs, MD, PhD, former vice president, exploratory and translational sciences for Merck Research Laboratories, has joined the company as head of global research and development.
EV | 11 April 2012
-
US FDA grants priority review to Bayer’s Xarelto
Bayer, together with its cooperation partner, Janssen Research & Development, announced that the US FDA has granted priority review designation to the supplemental New Drug Application (sNDA) filed on December 29, 2011 for the oral anticoagulant Xarelto.
EV | 09 April 2012
-
apceth, Indivumed to develop biomarker platform for targeted cellular therapies
apceth and Indivumed have entered into a partnership for the development of a predominantly tissue-based biomarker strategy for the treatment of solid cancers with cellular and / or gene therapeutics.
EV | 27 March 2012
-
GEA Pharma Systems develops inline moisture sensor
GEA Pharma Systems, in co-operation with NDC, has developed an inline moisture sensor for pharmaceutical drying systems.
EV | 26 March 2012
-
GEA Pharma appoints director of sales, business development for Latin America
GEA Pharma Systems has appointed Zósimo López Moreno as its director sales and business development for Latin America.
EV | 22 March 2012
-
Agilent Technologies’s Thought Leader Award supports Chris Evelo’s work at Maastricht University
Agilent Technologies the Agilent Technologies Foundation announced that Dr Chris Evelo and the department of bioinformatics at Maastricht University are the recipients of an Agilent Thought Leader Award supporting development of software to integrate different types of biological data. The goal of this award is to help accelerate breakthroughs in disease research by facilitating integrative systems biology approaches.
EV | 06 February 2012
-
ICON Development Solutions appoints general manager of Asia Pacific
ICON announced that its development solutions division has appointed Dr Daniel Tang as general manager, Asia Pacific. Dr Tang will lead the development of ICON’s early phase activities across the region, including bioanalytical laboratory services, and the development of strong links with key opinion leaders for early phase clinical testing.
EV | 12 December 2011
